Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Case Studies
Case Studies: Myeloproliferative Neoplasms
Expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
SORT BY:
A-Z
Recent
VIEW AS:
Grid
List
The Clinical Management of Primary Myelofibrosis
Diagnosis and Treatment of Myelofibrosis
Managing Uncontrolled Polycythemia Vera
A Case of Hydroxyurea Intolerant Polycythemia Vera
High-Risk Primary Myelofibrosis
Hydroxyurea Resistant Polycythemia Vera
Underlying Treatment of Myeloproliferative Neoplasms
Uncontrolled Polycythemia Vera
Harry Erba, MD, PhD, provides information on the diagnosis and treatment of patients with polycythemia vera
Srdan Verstovsek, MD, provides information on the diagnosis and treatment of patients with polycythemia vera
JTT Articles
The Role of Liquid Biopsy in NSCLC Continues to Emerge
Rare Incidence of ICI-Related Hepatotoxicity Frequently Ends in Treatment Discontinuation
Researchers Look to CAR T-Cell Therapy as Immunotherapy Outcomes Diminish in Glioblastoma
>> View Peer-Reviewed Articles
Most Popular
Key Takeaway Points in Phase III ALCYONE Trial for Multiple Myeloma
Finasteride Effective in Preventing Prostate Cancer
Enzalutamide Leads to Extended Radiographic PFS in Metastatic Hormone-Sensitive Prostate Cancer
Lenalidomide Maintenance Improves PFS, OS in Patients With Transplant-Eligible Multiple Myeloma
Publications
